Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis

Frontiers in Medicine

Rahul Kashyap¹  Vikas Bansal¹  Abhishek Bhurwal²  John C. O'Horo³  Romil Singh⁴  Ishita Mehra⁵  Ishita Gupta⁶  Janaki Makadia⁷  Nimisha Madas⁸  Kiran S. Mahapure⁹  Paige Armaly^1,10  Sahar Hassanain^1,11 

[1] Department of Anaesthesiology and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States;Department of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, NJ, United States;Department of Infectious Disease, Department of Anesthesiology and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States;Departments of Medicine, Metropolitan Hospital, Jaipur, India;Division of Pulmonary, Sleep and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States;Department of Internal Medicine, North Alabama Medical Center, Florence, AL, United States;Dr. Rajendra Prasad Government Medical College, Tanda, India;Gujrat Medical Education and Research Society Medical College, Vadodara, India;Mamata Medical College, Khammam, India;Senior Resident, Department of Plastic Surgery, KAHER J. N. Medical College, Belgaum, India;University of the West Indies, Nassau, Bahamas;Women Medical College, Abbottabad, Pakistan;

关键词: Remdesivir (GS-5734);    COVID-19;    SARS-CoV-2;    mortality;    systematic review;    meta-analysis;   

DOI  :  10.3389/fmed.2020.606429

来源: Frontiers

【 授权许可】

CC BY